Appili Therapeutics Announces Transfer to NEX

Halifax, Nova Scotia--(. - September 29, 2026) - Appili Therapeutics Inc. TSX:APLI (OTC Pink: APLIF) (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases, announces that it has applied to voluntarily delist its Class A common shar…